Affirming evolution of complex systems

Resurrection of 450 million year old protein illustrates how an integrated system evolved in a stepwise fashion

Written byCharles Choi
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
An ancient receptor appears sensitive to the same hormone that activates its modern descendant, providing clues to how a lock-and-key relationship evolved between a hormone and its far older receptor, according to this week's Science. These findings illustrate the means by which complex, tightly integrated parts could have evolved in a stepwise, Darwinian fashion.To obtain their findings, the researchers used phylogenic analyses to ?resurrect? a 450 million year old protein and determine the process that led it to its current form. "It's almost as though they had a time machine to go back and look at the ancient interactions," Richard Lenski at Michigan State University, who did not participate in this study, told The Scientist.The researchers, headed by Joseph Thornton at the University of Oregon in Eugene, focused on the history of the relationship between the steroid hormone aldosterone, currently only seen in tetrapods, and the mineralocorticoid receptor, which emerged some 75 million years before its partner.Using polymerase chain reaction (PCR) analysis, they identified a corticoid receptor in two jawless fishes, and the mineralocorticoid receptor and glucocorticoid receptor in a cartilaginous fish. Phylogenetic analysis indicated a gene duplication event of an ancestral corticoid receptor gave rise to both the mineralocorticoid receptor and the glucocorticoid receptor more than 450 million years ago, after jawless fishes diverged but before cartilaginous fish split from bony vertebrates.Further analyses revealed that the jawless and cartilaginous fish receptors are activated by very low doses of aldosterone, cortisol, and 11-deoxycorticosterone (DOC), but the glucocorticoid receptors of bony vertebrates were insensitive to aldosterone. This suggested the ancestral corticoid receptor could have been activated by aldosterone, but that sensitivity to aldosterone disappeared in the glucocorticoid receptors of bony vertebrates.The researchers then reconstructed the likely amino acid sequence of the ancestral corticoid receptor's ligand-binding domain using phylogeny and existing receptor sequences, and expressed the putative ancient receptor in cultured Chinese hamster ovary cells. They found that the reconstructed ancestral corticoid receptor is a sensitive and effective aldosterone receptor.The researchers suggest that the ancestral receptor?s response to aldosterone stemmed from its affinity for ancient ligands chemically similar to aldosterone, such as DOC, which differs from aldosterone by small moeities at only two positions. Subsequent analyses suggested that substitutions of only two amino acid sequences caused the glucocorticoid to lose its sensitivity to aldosterone."My assumption would have been that, as with androgen receptor and progesterone receptor, the steroid came first and that the ancestral receptor gradually evolved," Scott MacKenzie at the University of Glasgow in Scotland, who did not participate in this study, told The Scientist. He felt Thornton and colleagues "argued persuasively" for a "receptor-first" scenario.Nicolette Farman at the College of France in Paris, also not a co-author, told The Scientist she found the work "fascinating," and that future research could examine the evolution of the enzyme that metabolizes glucocorticoids to prevent them from inadvertently binding to the mineralocorticoid receptor. "It'd be nice to know when and where the enzyme evolved, which could help explore what role the ancestral corticoid receptor played and changed over time."Biological systems composed of highly integrated parts are a rallying cry for the intelligent design movement, which claims them as examples of so-called irreducible complexity that could not have formed in a stepwise manner under natural selection. "While I would say our work reveals a fundamental logical flaw in the irreducible complexity argument, that's not what motivated us. Questions of evolutionary biology did," study author Thornton told The Scientist. He and his colleagues next plan to examine other steroid hormone and receptor systems, such as those of estrogen and testosterone.Charles Choi cchoi@the-scientist.comLinks within this articleJ.T. Bridgham et al. "Evolution of hormone-receptor complexity by molecular exploitation," Science, April 7, 2006. http://www.sciencemag.orgK.Y. Kreeger. "Six scientists are added to ranks of prestigious MacArthur fellows," The Scientist, September 2, 1996 http://www.the-scientist.com/article/display/17138/Richard Lenski http://www.msu.edu/user/lenski/Joseph Thornton http://www.uoregon.edu/~joet/M. Greener. "Steroid action gets a rewrite," The Scientist, September 8, 2003. http://www.the-scientist.com/article/display/14063/D. Bruce, "Walking from water," The Scientist, July 4, 2002 http://www.the-scientist.com/article/display/20505/Scott MacKenzie http://www.medther.gla.ac.uk/mrc/mackenzie.htmN.S. Greenspan. "Not-so-intelligent design," The Scientist, March 4, 2002. http://www.the-scientist.com/article/display/12895/
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies